Edwards Lifesciences Corp. (EW)

215.07
4.40 2.00
NYSE : Health Technology
Prev Close 219.50
Open 218.19
Day Low/High 214.09 / 220.22
52 Wk Low/High 136.44 / 228.19
Volume 728.22K
Avg Volume 1.22M
Exchange NYSE
Shares Outstanding 207.97M
Market Cap 45.85B
EPS 3.50
P/E Ratio 63.51
Div & Yield N.A. (N.A)

Cramer: Here Are Many More Stocks in Loved Groups

Utilities, gold, turnarounds and more.

7 Names Popping Up on Bullish Chart Scans

Insurance, waste management, and medical equipment dominate the list.

Jim Cramer Says Don't Be Disappointed in Disney on 'Star Wars' Debut

Jim Cramer Says Don't Be Disappointed in Disney on 'Star Wars' Debut

Facebook is the way of the future, according to Jim Cramer, co-manager of Action Alerts PLUS portfolio and host of CNBC’s ‘Mad Money.'

Edwards Lifesciences Isn't Done Climbing

Traders could buy a breakout to a new high on EW, over $160, and then use a sell-stop below $149.

Bull Chart of the Week: Edwards Lifesciences

The upside here looks to be in the $175-$180 area.

Jim Cramer Says Buy Delta, Own Apple, Oil Is Overbought

Jim Cramer Says Buy Delta, Own Apple, Oil Is Overbought

Jim Cramer answered viewers' social media questions from the floor of the New York Stock Exchange Friday and said now is the time to buy airline stocks.

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer Says Buy Celgene at $113 or Below, Skyworks in the $70s

Jim Cramer answered viewers' Twitter from the floor of the New York Stock Exchange, commenting on Qorvo (QRVO), Celgene (CELG), and Boston Scientific (BSX).

Cramer Sees T-Mobile Pricing Impacts; Doesn't Recommends Gold ETFs

Cramer Sees T-Mobile Pricing Impacts; Doesn't Recommends Gold ETFs

Jim Cramer answers viewers' Twitter (TWTR) questions from the floor of the New York Stock Exchange.

Edwards Lifesciences upgraded at RBC

Edwards Lifesciences upgraded at BMO

Michael Kors Is a Bargain

Michael Kors Is a Bargain

The stock trades at the lowest valuation in its history.

The Second-Strongest Stock Market Sector Doesn't Jibe With the Strongest

You could throw darts at financials and health care and win. 

What Stocks to Buy Now

There are dozens of juicy opportunities in this market.

Market Rewards Biotech Latecomers

It shouldn't be possible, but it never seems too late to get in.

Cramer: Total Eclipse of a Bearish Sun

A lot of stocks are doing incredibly well. 

Which Stocks Are in Style?

Cybersecurity, retail among the most fashionable.

Violent Moves in a 'Scarface' Market

The 'dead bodies' are adding up.

Go With What's Worked, Part 1

Throughout this historic run, four groups have consistently led the market.

Cramer: Oil-and-Gas vs. Everything Else

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

Here's Your Thesis to Buy

This market provides a slew of reasons to buy right now.

Cramer: Stocks That Stand Out

There's a powerful collection of "what's working."

Finding Winning Charts Amid the Gloom

These quality names look appealing on the basis of 30-week moving average.

Bizarro World Continues

Where what the Fed does allegedly determines everything.